Avid Bioservices Inc (CDMO)

[EndoTarget]

CP,

I think the PR was written under pressure. It was abnormal not to PR such an important fact.

BUT, they kept something in the gun.

Because if you read carefully the recent patent document for INTERNATIONAL PROTECTION OF THE INVENTION, you will see that they can spefically determine where the cancer come from.

And the test is positive or negative at 50 picograms. With a specificity of 87%.

So, they will develop a test similar of PSA and with a baseline people would test every year to see if there is an elevation of exosome-PS...

ASTRONOMICAL, he said...

ET